Walgreen (WAG) Front-End Comps Up 1.6% in Jan.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Walgreen (WAG) Earnings Could Benefit as CVS (CVS) Halts Tobacco Sales; Goldman Comments
February 5, 2014 11:24 AM ESTGoldman Sachs maintained a Conviction Buy on Walgreen (NYSE: WAG) with a price target of $67.00. Analyst Robert P. Jones thinks Walgreen's January same-store-sales miss is overshadowed by news competitor CVS (NYSE: CVS) is ending sales of tobacco products.
... More
